research
Costimulatory molecule-deficient dendritic cell progenitors (MHC class II<sup>+</sup>, CD80(dim), CD86<sup>-</sup>) prolong cardiac allograft survival in nonimmunosuppressed recipients
- Publication date
- 15 September 1996
- Publisher
- 'Ovid Technologies (Wolters Kluwer Health)'